Molecules / Indapamide

Indapamide API manufacturers

CAS 26807-65-8 ATC C03BA11 Updated 9 July 2026
13
manufacturers with an active filing 11 of them hold a US DMF or a CEP
$749.05
median export price per kg $60.37 to $1244.60 · 9 exporters · 2025
104
shortage records on file across 6 countries
619
finished-dose makers across 46 regulators
Showing 13 of 13 manufacturers This list is ranked on evidence. Placement cannot be purchased.

Ranked API manufacturers

01

Ipca Laboratories

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds 2 valid CEPs for indapamide, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.

US DMF
None on file
CEP
2 valid
Last FDA inspection
2025 · VAI
GMP recognised in
19 markets
How this listing is sourced EDQM certificate database
View profile
02

Industriale Chimica

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF and one valid CEP for indapamide, filing since 2008. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.

US DMF
1 active
CEP
1 valid
Last FDA inspection
2022 · VAI
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
FDA, List of Drug Master Files
View profile
03

Biophore India Pharmaceuticals

India
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for indapamide, filing since 2023. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 2 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2024 · NAI
GMP recognised in
2 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
04

Quimica Sintetica

Spain
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for indapamide, filing since 1991. Its 2023 FDA inspection closed as VAI.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced FDA, List of Drug Master Files
View profile
05

Suzhou Lixin Pharmaceutical

China
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for indapamide, filing since 2023. Its 2023 FDA inspection closed as VAI.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile
06
Credentials confirmed against the regulator files on 25 July 2026

Holds one active US DMF for indapamide, filing since 1991. Its 2023 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.

US DMF
1 active
CEP
None on file
Last FDA inspection
2023 · VAI
GMP recognised in
6 markets
How this listing is sourced FDA, List of Drug Master Files
View profile
07

ORIL Industrie

France
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for indapamide, filing since 2020. Its 2023 FDA inspection closed as VAI.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile
08

PharmaZell

Germany
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for indapamide, filing since 2023. Its 2022 FDA inspection closed as VAI.

US DMF
None on file
CEP
1 valid
Last FDA inspection
2022 · VAI
GMP recognised in
Not established
How this listing is sourced EDQM certificate database
View profile
09

Bioindustria L.I.M

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for indapamide, filing since 2022. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced EDQM certificate database
View profile
10

Laboratori Alchemia

Italy
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for indapamide, filing since 2021. Its GMP is recognised in 2 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
2 markets
How this listing is sourced EDQM certificate database
View profile
11

Krka

Slovenia
Makes the API
Credentials confirmed against the regulator files on 25 July 2026

Holds one valid CEP for indapamide, filing since 2025. Its GMP is recognised in 5 markets.

US DMF
None on file
CEP
1 valid
Last FDA inspection
Not established
GMP recognised in
5 markets
How this listing is sourced EDQM certificate database
View profile
12

Registered with DAV (Vietnam) for indapamide. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile
13

SaVipharm J.S.C

Vietnam
Makes the APIFinished dose

Registered with DAV (Vietnam) for indapamide. Its GMP is recognised in 1 market.

US DMF
None on file
CEP
None on file
Last FDA inspection
Not established
GMP recognised in
1 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile

10 more manufacturers hold filings for indapamide

The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.

Quimica SinteticaSuzhou Lixin PharmaceuticalBioindustria Laboratorio Italiano MedicinaliORIL IndustriePharmaZellBioindustria L.I.MLaboratori AlchemiaKrkaCông ty cổ phần dược phẩm SaViSaVipharm J.S.C
Chat with Fred, your AI analyst

Contract manufacturers (4)

Torrent Pharmaceuticals India Delta Finochem India Ami Lifesciences India Grupo Azevedos Portugal

Contract manufacturers make to order rather than holding their own filing for this molecule.

Finished-dose makers (66)

Viatris United States Servier (Ireland) Industries Ireland Teva Israel Pharmascience Canada Les Laboratoires Servier Industrie France Torrent Pharmaceuticals India Zentiva, k.s Czech Republic Glenmark Pharmaceuticals s.r.o Czech Republic Apotex Canada Xepa-Soul Pattinson (Malaysia) Sdn Bhd Malaysia Eurofarma Laboratorios Brazil Rising United States Towa Pharmaceutical Europe, S.L Spain Sandoz Switzerland Zydus Lifesciences India "PRO.MED.CS Praha Czech Republic “Gedeon Richter” Hungary Jamp Pharma Canada Sanofi France Pharmaceutical Works Polpharma Poland

How this list is built

The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.

Active US DMFs
FDA, List of Drug Master Files
Valid CEPs
EDQM certificate database
Inspection outcomes
FDA inspection classifications
GMP certificates
EudraGMDP and national regulators
Price band
Customs export unit values for 2025. These are export values rather than contract prices for regulated-market grade material, which are higher.

Who makes indapamide?

Ask Fred which manufacturers are on record for indapamide and what filings they hold.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Also on this molecule

Price history 1 yrs Shortages 104 Recalls 1 Finished dose 66 Contract mfrs 4

Sold in these combinations

Indapamide + Perindopril Tert-Butylamine 2 APIs Perindopril + Indapamide 2 APIs Amlodipine + Perindopril + Indapamide 3 APIs

Fixed-dose combinations containing indapamide. Each page leads with the verified API makers of every component.